These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 29671211)
1. Characterisation of DOG-1 Expression in Salivary Gland Tumours and Comparison with Myoepithelial Markers. Khurram SA; Speight PM Head Neck Pathol; 2019 Jun; 13(2):140-148. PubMed ID: 29671211 [TBL] [Abstract][Full Text] [Related]
2. Epithelial membrane antigen and DOG1 expression in minor salivary gland tumours. Andrade EP; Teixeira LN; Montalli VAM; Garcia FM; Passador-Santos F; Soares AB; Araújo VC Ann Diagn Pathol; 2019 Dec; 43():151408. PubMed ID: 31629156 [TBL] [Abstract][Full Text] [Related]
3. Lysozyme Expression Can be Useful to Distinguish Mammary Analog Secretory Carcinoma from Acinic Cell Carcinoma of Salivary Glands. Mariano FV; Gómez CA; de Souza do Nascimento J; Dos Santos HT; Egal ES; Montalli VA; Vargas PA; de Almeida OP; Altemani A Head Neck Pathol; 2016 Dec; 10(4):429-436. PubMed ID: 27177644 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas. Abd Raboh NM; Hakim SA Int J Clin Exp Pathol; 2015; 8(8):9214-22. PubMed ID: 26464669 [TBL] [Abstract][Full Text] [Related]
5. DOG1: a novel marker of salivary acinar and intercalated duct differentiation. Chênevert J; Duvvuri U; Chiosea S; Dacic S; Cieply K; Kim J; Shiwarski D; Seethala RR Mod Pathol; 2012 Jul; 25(7):919-29. PubMed ID: 22460810 [TBL] [Abstract][Full Text] [Related]
6. Comparison of p63/p40 Expression With Myoepithelial Markers in Minor Salivary Gland Tumors. Teixeira LN; Janner ÉC; Teixeira T; Passador-Santos F; Martinez EF; Demasi APD; de Araújo NS; de Araújo VC Int J Surg Pathol; 2019 Jun; 27(4):360-371. PubMed ID: 30482064 [TBL] [Abstract][Full Text] [Related]
7. Glial Fibrillary Acidic Protein Expression Helps Distinguish Pleomorphic Adenoma from Histologic Mimics. Gorski Z; Purgina B; Wasserman JK Head Neck Pathol; 2022 Sep; 16(3):695-702. PubMed ID: 35064902 [TBL] [Abstract][Full Text] [Related]
8. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. Edwards PC; Bhuiya T; Kelsch RD Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic Utility of Immunohistochemical Expressions of IMP3 Versus DOG1 and p63 in Salivary Gland Tumors. Ibrahim TR; Ahmed MM; Hegazy AA Turk Patoloji Derg; 2020; 36(3):227-236. PubMed ID: 32692399 [TBL] [Abstract][Full Text] [Related]
10. NR4A3 Immunohistochemistry Reliably Discriminates Acinic Cell Carcinoma from Mimics. Wong KS; Mariño-Enriquez A; Hornick JL; Jo VY Head Neck Pathol; 2021 Jun; 15(2):425-432. PubMed ID: 32910350 [TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase VI: a novel marker for salivary serous acinar differentiation and its application to discriminate acinic cell carcinoma from mammary analogue secretory carcinoma of the salivary gland. Hsieh MS; Jeng YM; Jhuang YL; Chou YH; Lin CY Histopathology; 2016 Apr; 68(5):641-7. PubMed ID: 26212680 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors. Rotellini M; Palomba A; Baroni G; Franchi A Appl Immunohistochem Mol Morphol; 2014; 22(5):390-4. PubMed ID: 23958548 [TBL] [Abstract][Full Text] [Related]
13. PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities. Katabi N; Xu B; Jungbluth AA; Zhang L; Shao SY; Lane J; Ghossein R; Antonescu CR Histopathology; 2018 Jan; 72(2):285-293. PubMed ID: 28796899 [TBL] [Abstract][Full Text] [Related]
14. Comparison of p63 and p40 (ΔNp63) as Basal, Squamoid, and Myoepithelial Markers in Salivary Gland Tumors. Owosho AA; Aguilar CE; Seethala RR Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):501-8. PubMed ID: 26230372 [TBL] [Abstract][Full Text] [Related]
15. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma. Hsieh MS; Lee YH; Chang YL Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192 [TBL] [Abstract][Full Text] [Related]
16. P63 expression can be used in differential diagnosis of salivary gland acinic cell and mucoepidermoid carcinomas. Sams RN; Gnepp DR Head Neck Pathol; 2013 Mar; 7(1):64-8. PubMed ID: 23054955 [TBL] [Abstract][Full Text] [Related]
17. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma. Mito JK; Jo VY; Chiosea SI; Dal Cin P; Krane JF Histopathology; 2017 Oct; 71(4):511-521. PubMed ID: 28463429 [TBL] [Abstract][Full Text] [Related]